Assessment of mother-to-child HIV-1 and HIV-2 transmission: An AIDS reference laboratory collaborative study

HIV Medicine

Volumn 10, Issue 3, 2009, Pages 182-190

  Pádua, Elizabeth ^a   Almeida, C ^a   Nunes, B ^a   Cortes Martins, H ^a   Castela, J ^b   Neves, C ^c   Paixao M T ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Maternity Alfredo de Costa   (Portugal)

^c Department of Pediatrics   (Portugal)

Author keywords

Algorithm for diagnosis; False negativeresults; HIV 1; HIV 2; Mother to childtransmission; Portugal; ProviralDNA

Indexed keywords

ANTIRETROVIRUS AGENT; PRIMER DNA; VIRUS DNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INFECTION RISK; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN; NEWBORN CARE; POLYMERASE CHAIN REACTION; PORTUGAL; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; VERTICAL TRANSMISSION; ALGORITHM; CLINICAL TRIAL; CONFIDENCE INTERVAL; HEALTH CARE DELIVERY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFANT; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; TRANSMISSION;

ALGORITHMS; ANTI-HIV AGENTS; CONFIDENCE INTERVALS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMERASE CHAIN REACTION; PORTUGAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 61449221886     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00669.x     Document Type: Article

References (32)

1. UNAIDS/WHO AIDS Epidemic Update: December 2007. http://data.unaids.org/ pub/EpiSlides/2007/2007_EpiUpdate_en.pdf.
2. CDC, Mofenson LM, Taylor AW et al. Achievements in public health. Reduction in perinatal transmission of HIV infection -United States, 1985-2005. Morb Mortal Wkly Rep 2006; 55: 592-597.
3. Jamieson DJ, Clark J, Kourtis AP et al. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol 2007; 197 (Suppl.): S26-S32.
4. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 458-465.
5. Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS 2002; 16: 1991-1999.
6. The European Mode of Delivery Collaboration. Elective caesarean-section vs. vaginal delivery in prevention of vertical HV-1 transmission: A randomised clinical trial. Lancet 1999; 353: 1035-1039.
7. The International Perinatal HIV Group. Mode of delivery and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies. N Engl J Med 1999; 340: 977-987.
8. Connor EM, Serling RS, Gelber RD et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
9. Cooper ER, Charurat M, Mofenson L et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29: 484-494.
10. CDC. U.S. Public Health Service Task Force Recommendations for Use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Morb Mortal Wkly Rep 2002; 51 (RR18): 1-38.
11. Kourtis AP, Duett A. Prevention of perinatal HIV transmission: A review of novel strategies. Expert Opin Investig Drugs 2003; 12: 1535-1544.
12. Coordenação Nacional para a Infecção VIH/SIDA. Recomendações Portuguesas para o Tratamento da Infecção VIH/SIDA 2007. Available at: http://www.sida.pt.
13. Direcção-Geral Saúde. Gravidez e Vírus da Imunodeficiência Humana. Circular Normativa N°1/DSMIA 2004. Available at: http://www.dgs.pt.
14. Nourse CB, Butler KM. Perinatal transmission of HIV and diagnosis of HIV infection in infants: A review. Irish J Med Sci 1998; 167: 28-32.
15. Nesheim SR. The diagnosis and management of perinatal HIV infection. Clin Obstet Gyn 1996; 39: 396-410.
16. Parry JV, Mortimer PP, Perry KR, Pillay D, Zuckerman M. Towards error-free HIV diagnosis: Guidelines on laboratory practice. Commun Dis Public Health 2003; 6: 334-350.
17. O'Shea S, Mullen J, Tong CY. Pediatric diagnosis of human immunodeficiency virus type 1 infection: The problem of false negative DNA polymerase chain reaction results. Pediatr Infect Dis J 2003; 22: 476-477.
18. Lyall EGH, Taylor GP, Clarke J, McLure MO. Polymerase chain reaction diagnosis of human immunodeficiency virus infection. Pediatr Infect Dis J 2003; 22: 295.
19. Esteves A, Parreira R, Venneno T et al. Molecular epidemiology of HIV type 1 in Portugal: High prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002; 5: 313-325.
20. Palma AC, Araújo F, Duque V, Borges F, Paixão MT, Camacho R. Portuguese SPREAD Network. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect Genet Evol 2007; 7: 391-398.
21. Faria A, Pádua E, Avillez F. PCR: Experiência laboratorial no diagnóstico da infecção por VIH-1. 7th Congresso de Patologia Clínica. Lisbon, Portugal, November 1994 [Abstract 70].
22. Faria A, Pádua E, Valle H et al. Diagnóstico laboratorial da infecção pelo VIH em crianças nascidas de mães seropositivas. 3rd Congresso Nacional sobre SIDA. Maia, Portugal, May 1997 [Abstract B3].
23. Kirk O, Mocroft A, Katzenstein TL et al. Changes in use of antiretroviral therapy in regions of Europe over time. AIDS 1998; 12: 2031-2039.
24. Perinatal HIV Guidelines Working Group. Public Health Service Task Force Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 1-96. Available at: http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf 2007.
25. Zar JH. Biostatistical Analysis. London: Prentice Hall, 1996.
26. Berry N, Ariyoshi K, Jaffar S et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1998; 1: 457-468.
27. Semple M, Loveday C, Weller I, Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991; 35: 38-45.
28. Berry N, Ariyoshi K, Jobe O et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4 lymphopaenia in HIV type-2-infected individuals. AIDS Res Hum Retroviruses 1994; 10: 1031-1037.
29. Zazzi M, Romano L, Catucci M et al. Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to test HIV-1 DNA in clinical specimens by PCR. J Clin Microbiol 1995; 33: 205-208.
30. Thorne C, Newell ML. HIV. Semin Fetal Neonatal Med 2007;12: 174-181.
31. Pádua E, Cortes-Martins H, Miguel R, Almeida C, Sobral R, Paixão MT. Vertical Transmission of HIV-1 and HIV-2 infections studied at the AIDS Reference Laboratory in Portugal: 1999-2001. 14th International AIDS Conference. Barcelona, Spain, July 2002 [Abstract ThPeC7425].
32. Cavaco-Silva P, Taveira N, Rosado L et al. Virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission. J. Virol 1998; 72: 3418-3422.